Waning humoral immunity in coronavirus disease patients has raised concern over usefulness of serologic testing. We investigated antibody responses of 58 persons 8 months after asymptomatic or mildly symptomatic infection with severe acute respiratory syndrome coronavirus 2. For 3 of 4 immunoassays used, seropositivity rates were high (69.0%–91.4%).
All Keywords
【저자키워드】 COVID-19, 2019 novel coronavirus disease, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, antibody, ELISA, ECLIA, 【초록키워드】 coronavirus, Antibody Response, immunoassay, Humoral immunity, Asymptomatic, Patient, serologic testing, symptomatic infection, acute respiratory syndrome, investigated, raised, 【제목키워드】 response, Month,
【저자키워드】 COVID-19, 2019 novel coronavirus disease, coronavirus disease, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, SARS-CoV-2, antibody, ELISA, ECLIA, 【초록키워드】 coronavirus, Antibody Response, immunoassay, Humoral immunity, Asymptomatic, Patient, serologic testing, symptomatic infection, acute respiratory syndrome, investigated, raised, 【제목키워드】 response, Month,
코로나바이러스 질환 환자의 체액성 면역 약화는 혈청학적 검사의 유용성에 대한 우려를 불러일으켰습니다. 우리는 중증급성호흡기증후군 코로나바이러스 2에 의한 무증상 또는 경증 감염 후 8개월 후 58명의 항체 반응을 조사했습니다. 사용된 4개의 면역 분석 중 3개의 경우 혈청 양성률이 높았습니다(69.0%-91.4%).